Letter to the Editor
Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib
Limei Hu1, Youjun Xie1, Hongying Zhao
Corresponding author
wanzhy196344@163.com
Corresponding author at: Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, 6 Taoyuan Road, Nanning, Guangxi, China.
Corresponding author at: Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, 6 Taoyuan Road, Nanning, Guangxi, China.
Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi, China
Read
2501
Timeswas read the article
737
Total PDF
1764
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 58 | 46 | 104 |
| 2025 5 | 103 | 62 | 165 |
| 2025 4 | 64 | 50 | 114 |
| 2025 3 | 86 | 40 | 126 |
| 2025 2 | 80 | 29 | 109 |
| 2025 1 | 56 | 30 | 86 |
| 2024 12 | 60 | 42 | 102 |
| 2024 11 | 87 | 52 | 139 |
| 2024 10 | 61 | 38 | 99 |
| 2024 9 | 66 | 57 | 123 |
| 2024 8 | 383 | 72 | 455 |
| 2024 7 | 404 | 77 | 481 |
| 2024 6 | 56 | 32 | 88 |
| 2024 5 | 58 | 26 | 84 |
| 2024 4 | 60 | 32 | 92 |
| 2024 3 | 64 | 37 | 101 |
| 2024 2 | 18 | 15 | 33 |
Show all
